| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |